Cargando…
CHEK2 mutations and papillary thyroid cancer: correlation or coincidence?
We report the case of a breast cancer survivor, diagnosed with an underlying CHEK2 c.1100delC heterozygosity, who developed a papillary thyroid cancer 5 years later. A CHEK2 c.1100delC (likely) pathogenic variant is associated with an increased risk of breast, prostate and colorectal cancer and ther...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802479/ https://www.ncbi.nlm.nih.gov/pubmed/35101071 http://dx.doi.org/10.1186/s13053-022-00211-7 |